“To meet new demands, we invested in a brand new EpiShuttle for Covid-19 patients. It is perfectly suited for longer trips. As of now, almost 20 percent of all our patients are infected with Covid-19, and the EpiShuttle has become an important component in our range of medical competencies”, says Eva Kluge, Chief Commercial Officer, in Air Alliance Medflight.
Air Alliance Medflight has assisted patients worldwide since 1993. Since March, they have been to destinations with limited healthcare systems, especially after the tourist market broke down. For example, Western Africa and Central Asia have been important destinations for the company. Many of these countries have a large number of severely ill covid-19 patients.
Air Alliance Medflight chose the EpiShuttle to give their patients the best possible care. Among other things, the comfort and reduced feeling of constriction for the patients inside the EpiShuttle was important reasons. In addition, the possibility to give the patient treatment without contaminating the environment.
“There are big differences between different portable medical isolation units produced. The demand from our patients and the medical quality have led us to opt for the EpiShuttle. It is better than earlier models, and gives our clinicals new and decisive features”, explains says Eva Kluge, Chief Commercial Officer, in Air Alliance Medflight.